These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2875725)

  • 21. Comparison between the continuous infusion of vecuronium and the intermittent administration of pancuronium and vecuronium.
    Noeldge G; Hinsken H; Buzello W
    Br J Anaesth; 1984 May; 56(5):473-7. PubMed ID: 6144316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuromuscular blockade following high-dose vecuronium administration].
    Otagiri T; Nishizawa M; Narita M; Kiyono S
    Masui; 1990 Feb; 39(2):174-83. PubMed ID: 1969971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromuscular blockade with vecuronium in paediatric patients with burn injury.
    Mills AK; Martyn JA
    Br J Clin Pharmacol; 1989 Aug; 28(2):155-9. PubMed ID: 2570602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade.
    Rørvik K; Husby P; Gramstad L; Vamnes JS; Bitsch-Larsen L; Koller ME
    Br J Anaesth; 1988 Aug; 61(2):180-5. PubMed ID: 2901270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacology of vecuronium in children. Studies during nitrous oxide and halothane in oxygen anaesthesia.
    Meistelman C; Loose JP; Saint-Maurice C; Delleur MM; da Silva GL
    Br J Anaesth; 1986 Sep; 58(9):996-1000. PubMed ID: 2875726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers.
    Caldwell JE; Szenohradszky J; Segredo V; Wright PM; McLoughlin C; Sharma ML; Gruenke LD; Fisher DM; Miller RD
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1216-22. PubMed ID: 7932174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):497-500. PubMed ID: 6134535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of vecuronium requirements for stable mechanical effect: comparison with or without previous succinylcholine administration.
    d'Hollander A; Agoston S; Barvais L; Massaut J; Baurain M
    Anesth Analg; 1985 Mar; 64(3):319-22. PubMed ID: 2858168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vecuronium and atracurium in patients with end-stage renal failure. A comparative study.
    Lepage JY; Malinge M; Cozian A; Pinaud M; Blanloeil Y; Souron R
    Br J Anaesth; 1987 Aug; 59(8):1004-10. PubMed ID: 2888474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bile salts and neuromuscular blocking agents.
    Westra P; Houwertjes MC; Wesseling H; Meijer DK
    Br J Anaesth; 1981 Apr; 53(4):407-15. PubMed ID: 6112011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of biliary obstruction on muscle relaxation with vecuronium.
    Orko R; Alila A; Rosenberg PH
    Eur J Anaesthesiol; 1988 Jan; 5(1):9-14. PubMed ID: 2897913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuromuscular blocking effects of atracurium, vecuronium and pancuronium during bolus and infusion administration.
    Gramstad L; Lilleaasen P
    Br J Anaesth; 1985 Nov; 57(11):1052-9. PubMed ID: 2864943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some effects of diisopropyl phenol (ICI 35 868) on the pharmacodynamics of atracurium and vecuronium in anaesthetized man.
    Robertson EN; Fragen RJ; Booij LH; van Egmond J; Crul JF
    Br J Anaesth; 1983 Aug; 55(8):723-8. PubMed ID: 6136286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrical and mechanical responses after neuromuscular blockade with vecuronium, and subsequent antagonism with neostigmine or edrophonium.
    Astley BA; Katz RL; Payne JP
    Br J Anaesth; 1987 Aug; 59(8):983-8. PubMed ID: 2888476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia.
    Engbaek J; Ording H; Pedersen T; Viby-Mogensen J
    Br J Anaesth; 1984 Sep; 56(9):953-7. PubMed ID: 6147154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological profile of neuromuscular blocking agents: present and future trends.
    Agoston S
    Acta Anaesthesiol Belg; 1988; 39(3 Suppl 2):235-7. PubMed ID: 2902727
    [No Abstract]   [Full Text] [Related]  

  • 39. [The dose-response relationship and time course of the neuromuscular blockade by alcuronium].
    Pühringer F; Adler R; Mitterschiffthaler G; Koller J; Mair P; Khünl-Brady KS; Agoston S
    Anaesthesist; 1990 Oct; 39(10):508-12. PubMed ID: 1980578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetics and pharmacodynamics of vecuronium in children].
    Steinbereithner K; Fitzal S; Schwarz S; Gilly H; Semsroth M; Weindlmayr-Goettel M
    Cah Anesthesiol; 1984; 32(1):5-10. PubMed ID: 6152193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.